Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301.
Miller AA; Murry DJ; Owzar K; Hollis DR; Kennedy EB; Abou-Alfa G; Desai A; Hwang J; Villalona-Calero MA; Dees EC; Lewis LD; Fakih MG; Edelman MJ; Millard F; Frank RC; Hohl RJ; Ratain MJ; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2009, vol. 27, issue 11, p 1800, ISSN 15277755. ISBN 15277755.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef